| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 09/18/2001 | US6291471 Use of apomorphine for the treatment of organic erectile dysfunction in males |
| 09/18/2001 | US6291469 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation |
| 09/13/2001 | WO2001066524A2 Intermediates useful for the synthesis of huperzine a |
| 09/13/2001 | WO1997014683A3 Phenanthridine derivatives, methods of producing them and medicaments containing phenanthridine derivatives |
| 09/12/2001 | EP1131296A2 Synthesis of intermediates useful in preparing tricyclic compounds |
| 09/12/2001 | CN1312812A Muscarinic agonists and antagonists |
| 09/12/2001 | CN1070852C Process for preparing 14-o-acylate of aconite alkaloid type compounds |
| 09/12/2001 | CN1070841C Carboxylic acid derivatives, their preparation and their use |
| 09/11/2001 | US6288077 2,3-methano-amino acid compounds |
| 09/11/2001 | US6288055 Analgesic agents |
| 09/07/2001 | WO2001064649A1 Process for the manufacture of 1,8-naphthalimide |
| 09/07/2001 | WO2001064647A1 Isoquinoline derivatives as pde4 inhibitors |
| 09/07/2001 | WO2001064645A2 Derivatives of quinoline as alpha-2 antagonists |
| 09/07/2001 | CA2400657A1 Derivatives of quinoline as alpha-2 antagonists |
| 09/05/2001 | EP1129089A1 Spiro-indolines as y5 receptor antagonists |
| 09/05/2001 | EP1129077A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 09/05/2001 | EP0862556B1 17-alkyl-7-substituted-4-aza steroid derivatives |
| 09/05/2001 | CN1311777A High affinity ligands for nociceptin receptor ORL-1 |
| 08/30/2001 | WO2001062736A1 Aryl fused azapolycyclic compounds |
| 08/30/2001 | WO2001015656A3 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents |
| 08/29/2001 | CN1310702A Nitric ester and nitrate salts of specific drugs |
| 08/28/2001 | US6280933 Multichromophore fluorescent probes using DNA intercalation complexes |
| 08/23/2001 | US20010016585 Antitumor agent |
| 08/22/2001 | EP1125929A1 Method for making (-)-(2R,4S)-4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester |
| 08/21/2001 | US6277990 For therapy of systemic and local inflammatory conditions. |
| 08/21/2001 | US6277872 Antiischemic agents; brain disorders |
| 08/21/2001 | US6277859 Highly selective kappa-opioid agonists useful as analgesics and diuretics with reduced physiological side effects |
| 08/16/2001 | WO2001058875A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | WO2001058488A1 Remedies for sjoegren's syndrome |
| 08/16/2001 | US20010014681 Compounds useful for inhibition of farnesyl protein transferase |
| 08/16/2001 | EP1123931A1 Tricylic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 08/16/2001 | EP1123918A1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 08/16/2001 | EP1123285A1 Substituted benzopyran analogs for the treatment of inflammation |
| 08/16/2001 | EP1123099A1 Novel indenoisoquinolines as antineoplastic agents |
| 08/16/2001 | EP0839137B1 Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |
| 08/16/2001 | EP0677050B1 Novel pyridone carboxylic acid derivatives |
| 08/16/2001 | CA2416343A1 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | CA2399800A1 Remedies for sjoegren's syndrome |
| 08/15/2001 | CN1308606A Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use pharmaceutical preparations comprising them |
| 08/14/2001 | US6274768 Acridin derivatives |
| 08/14/2001 | CA2226406C Novel pyridone carboxylic acid derivatives |
| 08/08/2001 | CN1306960A Method for extracting huperzine A as acetylcholinesterase depressant |
| 08/07/2001 | US6271411 Process for preparing 2-aryl-substituted indenes |
| 08/07/2001 | US6271379 Intermediates useful for the synthesis of huperzine A |
| 08/07/2001 | US6271253 Cyclooxygenase inhibitors |
| 08/02/2001 | US20010011139 Polynucleotides labeled with dibenzorhodamine dyes |
| 08/01/2001 | EP1119570A1 Tricyclic delta3-piperidines as pharmaceuticals |
| 08/01/2001 | EP1119553A1 Monomeric and dimeric heterocycles, and therapeutic uses thereof |
| 07/31/2001 | US6268530 Process to prepare 5-formylvaleric acid |
| 07/31/2001 | US6268510 Rearrangement process and tricyclic and tetracyclic compounds |
| 07/25/2001 | EP0752857B1 AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS (2-AMINOETHYL)AMINO]BENZO g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1068882C Process for preparation of 5-(alkoxymethyl)-2,3-pyridinedicarboximide compounds |
| 07/24/2001 | US6265431 Cycloalkano-indole and -azaindole derivatives |
| 07/24/2001 | US6265417 Muscle relaxants |
| 07/24/2001 | US6265415 Compounds for inhibition of gastric acid secretion |
| 07/24/2001 | US6265408 Sulphonamide derivatives and their use in the treatment of CNS disorders |
| 07/19/2001 | WO2001051471A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and the use thereof as medicaments |
| 07/19/2001 | WO2001051470A1 Phenanthridine-n-oxides |
| 07/19/2001 | CA2396026A1 Phenanthridine-n-oxides |
| 07/18/2001 | EP1115708A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors |
| 07/18/2001 | EP0713870B1 Novel fused indan derivative and pharmaceutically acceptable salt thereof |
| 07/18/2001 | CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 07/17/2001 | US6262064 Octahydrobenzo[f]quinoline-based receptor agonists and antagonists |
| 07/17/2001 | US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation |
| 07/12/2001 | WO2001049292A1 Oral mucosal dosage forms of apomorphine |
| 07/12/2001 | US20010007905 Nucleic acids labelled with extended rhodamine dyes |
| 07/12/2001 | US20010007680 Use of a film coating as taste-masking coating of oral dosage forms |
| 07/12/2001 | CA2394297A1 Oral mucosal dosage forms of apomorphine |
| 07/11/2001 | EP1114032A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 07/11/2001 | EP1114031A1 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors |
| 07/11/2001 | EP1015461A4 Novel compounds for generating chemiluminescence with a peroxidase |
| 07/11/2001 | CN1302804A Dihydrofuro [3,4-b] quinoline-1-ketone type compound, its preparation method and medicinal composition containing these compounds |
| 07/11/2001 | CN1302800A Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 07/11/2001 | CN1068327C 2,7-Substituted octahydro-1H-pyrido [1,2-alpha]pyrazin derivatives |
| 07/10/2001 | US6258829 Antiarrthmia agents and cardiovascular disorders |
| 07/10/2001 | US6258469 Light emitting diodes |
| 07/10/2001 | CA2059792C Tricyclic compounds and intermediates thereof |
| 07/05/2001 | WO2001047893A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2394097A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 07/04/2001 | EP1112272A1 Muscarinic agonists and antagonists |
| 07/04/2001 | CN1302301A Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidine sas inhibitors of cellular proliferation |
| 07/03/2001 | CA2216231C Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 06/28/2001 | WO2000077010A3 Substituted heterocycle fused gamma-carbolines |
| 06/28/2001 | DE19961897A1 Verwendung eines Filmüberzuges als geschmacksmaskierendes Coating von pharmazeutischen Darreichungsformen Using a film coating as taste coating of pharmaceutical dosage forms |
| 06/27/2001 | EP1110954A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 06/27/2001 | EP1110945A2 Azocompounds for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition |
| 06/27/2001 | EP1110544A2 Use of a film coating as taste masking coating for oral dosage forms |
| 06/27/2001 | CN1301256A Improved method for preparing pharmaceutically valuable norbenzomorphane derivatives |
| 06/27/2001 | CN1301154A Amide derivatives and nociceptin antagonists |
| 06/27/2001 | CN1300590A Use of coating as taste masking agent for oral preparation |
| 06/26/2001 | US6252090 Compounds having activity as inhibitors of cytochrome P450RAI |
| 06/26/2001 | US6251916 For therapy of pain |
| 06/26/2001 | US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics |
| 06/20/2001 | EP1107753A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/19/2001 | US6248890 Reacting a naphthalimide diol with a fatty acid having from 8 to 24 carbon atoms |
| 06/19/2001 | US6248884 Particularly well suited for use in automated fluorescence-based dna sequencing systems using an excitation light source having a wavelength greater than about 630 nm, e.g., a helium-neon gas laser or a solid state diode laser. |